Pudendal Neuralgia: A Comprehensive Guide to Diagnosis and Treatment

Pudendal Neuralgia: A Comprehensive Clinical Guide to Diagnosis, Mechanisms, and Advanced Management

Pain Spa | Dr M. Krishna | Specialist Interventional Pain Management

Introduction: Understanding Pudendal Neuralgia

Pudendal neuralgia is one of the most challenging and frequently under-recognised causes of chronic pelvic pain. Despite increasing awareness, it remains widely misunderstood, often leading to prolonged diagnostic delays and significant patient morbidity.

Patients typically present after seeing multiple specialists, including urologists, gynaecologists, colorectal surgeons, and physiotherapists. Investigations are often normal, and symptoms are frequently attributed to conditions such as chronic prostatitis, vulvodynia, or nonspecific pelvic pain syndromes. This diagnostic uncertainty contributes to patient frustration, psychological distress, and delayed access to effective treatment.

The fundamental issue is that pudendal neuralgia is a clinical diagnosis, not one that is defined by imaging or laboratory findings. Recognition depends on identifying a characteristic symptom pattern, supported by structured criteria and confirmed through targeted interventions such as diagnostic nerve blocks.

When diagnosed appropriately, a stepwise and targeted management strategy can lead to substantial improvement. Conversely, failure to recognise the condition early may result in central sensitisation and chronic disability.

What Is Pudendal Neuralgia?

Pudendal neuralgia is a neuropathic pain syndrome involving the pudendal nerve, characterised by pain in the anatomical territory of the nerve — including the perineum, external genitalia, and anorectal region.

The defining feature is pain that worsens with sitting and improves with standing or lying down, reflecting mechanical irritation or compression of the nerve.

The condition may arise from multiple mechanisms:

• Mechanical compression or entrapment
• Inflammatory irritation
• Traumatic injury
• Functional compression from pelvic floor muscles

It is important to recognise that pudendal neuralgia is a syndrome rather than a single diagnosis. While pudendal nerve entrapment is a common cause, other mechanisms such as surgical injury, radiation fibrosis, and myofascial dysfunction may produce similar clinical presentations.

A key diagnostic feature is that patients are not typically woken from sleep by the pain, which helps distinguish pudendal neuralgia from other structural or pathological causes.

Anatomy of the Pudendal Nerve and Why It Matters Clinically

The pudendal nerve arises from the S2–S4 nerve roots and follows a complex anatomical course through the pelvis, making it vulnerable to compression at several key points.

After exiting the pelvis via the greater sciatic foramen, it passes around the ischial spine and travels between the sacrospinous and sacrotuberous ligaments, one of the most common sites of entrapment. It then enters Alcock’s canal, a fascial tunnel along the lateral wall of the ischiorectal fossa, before dividing into terminal branches supplying the perineum, genitals, and anal sphincter.

This anatomical pathway has direct clinical relevance:

Understanding these sites is essential for:

• Accurate diagnosis
• Targeted nerve blocks
• Effective interventional procedures

Clinical Presentation: How Pudendal Neuralgia Presents

Patients with pudendal neuralgia typically present with chronic perineal or pelvic pain, often described as burning, tingling, stabbing, or pressure-like.

The hallmark feature is pain that is significantly worse when sitting and improves with standing or lying down. This positional nature of pain is one of the most important diagnostic clues.

Symptoms often progress throughout the day, particularly with prolonged sitting. Many patients report an inability to sit comfortably and may adopt compensatory behaviours such as sitting on one side or using cushions.

Associated symptoms may include:

• Sexual dysfunction (dyspareunia, erectile dysfunction)
• Urinary symptoms (urgency, frequency, discomfort)
• Bowel symptoms (pain with defecation)

A key distinguishing feature is that pain does not wake patients at night, which helps differentiate pudendal neuralgia from more serious pathologies.

The condition significantly impacts quality of life, affecting work, mobility, and psychological wellbeing.

Causes of Pudendal Neuralgia

Pudendal neuralgia is not a single-etiology condition. It is better understood as a clinical pain syndrome arising from several mechanisms that lead to irritation, inflammation, compression, or entrapment of the pudendal nerve. In some patients, there is a clearly identifiable anatomical entrapment; in others, symptoms arise from a combination of pelvic floor dysfunction, prior trauma, surgery, repetitive mechanical stress, or neuropathic change without a single fixed compressive lesion. That is one of the reasons why the condition can be diagnostically difficult and why management often needs to be individualised rather than formulaic.

The most widely recognised mechanism is mechanical entrapment. The pudendal nerve is particularly vulnerable where it travels between the sacrospinous and sacrotuberous ligaments and again within Alcock’s canal. Surgical and imaging-based series suggest that the interligamentous region is one of the most common sites of clinically relevant compression, although distal entrapment within Alcock’s canal is also well described and may account for persistent symptoms in patients whose pain pattern involves several terminal branches.

A second major cause is obstetric trauma. Vaginal delivery can stretch or compress the pudendal nerve, particularly in difficult or instrumented births. In some patients this produces transient neuropathy that improves; in others, symptoms persist and evolve into chronic neuropathic pelvic pain. This mechanism is especially important when the onset of symptoms follows childbirth and when pelvic floor dysfunction coexists.

Pelvic or urogenital surgery is another important cause. Direct injury to the nerve can occur during pelvic procedures, but in many cases the problem is not immediate transection; rather, it is postoperative scarring, fibrosis, altered tissue planes, or tension around the nerve. Mesh procedures, sacrospinous fixation, prostate surgery, and other pelvic operations should all raise suspicion when symptoms begin after intervention.

Repetitive perineal compression, particularly from cycling, is a classic and clinically important mechanism. Long-distance cyclists and high-intensity cyclists may develop irritation of the pudendal nerve from repeated compression against the saddle, particularly at Alcock’s canal. In men, this can present with penile numbness, perineal pain, scrotal discomfort, or erectile and ejaculatory symptoms. Some cycling-related cases improve after stopping the aggravating activity, with case reports describing spontaneous resolution over several weeks, but not all do, and a proportion evolve into established neuralgia.

A further group of patients develop symptoms in association with pelvic floor muscle spasm and myofascial dysfunction. In these cases, the nerve may not be trapped by a discrete anatomical structure, but chronic hypertonicity of surrounding muscles can create ongoing irritation, impaired nerve gliding, and a self-perpetuating pain cycle. This is clinically important because these patients may not respond fully to medication or nerve procedures alone unless the muscular component is treated directly.

There are also several cannot-miss causes that mandate further investigation. Pelvic or sacral malignancy can compress the pudendal nerve and mimic pudendal neuralgia, but the presentation is often atypical. Similarly, space-occupying lesions such as abscesses, haematomas, or mass lesions may produce pudendal-distribution pain. Radiation-induced pudendal neuropathy is another important cause, particularly after pelvic cancer treatment. This tends to reflect fibrosis and progressive nerve injury rather than a clean entrapment syndrome and may present months or years after treatment.

Among the less common and emerging causes, Tarlov cysts are frequently discussed. The key point is that they are often incidental. In one series cited in your source material, 16% of patients with pudendal neuralgia had Tarlov cysts, yet 81.6% of these showed discordance between cyst location and pain laterality, suggesting that these cysts are often not the true pain generator. Neurovascular entrapment has also been proposed, particularly in laparoscopic literature, but remains a developing concept rather than a routine clinical diagnosis.

A practical way to think about causation is shown below:

Pudendal Neuralgia, Pudendal Nerve Entrapment, Prevalence, and Risk Factors

It is important to distinguish between pudendal neuralgia and pudendal nerve entrapment, because they are not interchangeable terms. Pudendal neuralgia is the broader clinical syndrome: chronic neuropathic pain in the pudendal nerve distribution. Pudendal nerve entrapment is one specific anatomical cause of that syndrome, in which the nerve is physically compressed, most commonly between the sacrospinous and sacrotuberous ligaments or within Alcock’s canal. The Nantes criteria were specifically designed to identify pudendal neuralgia due to pudendal nerve entrapment, not every possible form of pelvic neuropathic pain.

This distinction matters because entrapment is potentially amenable to decompression or targeted intervention, whereas non-entrapment causes—such as inflammation, radiation fibrosis, surgical trauma, or secondary myofascial compression—may require a different therapeutic emphasis. A patient can absolutely have pudendal neuralgia without having a clean surgically treatable entrapment lesion. That is why it is unhelpful to reduce the whole condition to a single procedural diagnosis.

Clinically, the pattern most suggestive of entrapment is the familiar Nantes-type presentation:

• pain in the pudendal territory,
• worsened by sitting,
• not waking the patient at night,
• no objective sensory loss,
• and a positive response to diagnostic block.

By contrast, certain features suggest that the pain may be due to another mechanism rather than classic entrapment. These include nocturnal awakening, clear sensory deficit, focal pinpoint pain suggesting neuroma, or other neurological abnormalities. These cases should not simply be forced into a pudendal entrapment framework; they should prompt reconsideration of the diagnosis and appropriate imaging.

In terms of prevalence, pudendal nerve entrapment is traditionally described as uncommon, with one estimate of about 1 per 100,000. However, your source documents correctly emphasise that this almost certainly underestimates the real burden of disease. The condition is widely under-recognised, frequently misdiagnosed, and lacks a gold-standard single diagnostic test. In chronic pain cohorts, one study cited in your material suggests that pudendal neuralgia may account for 4% or more of patients, which is far higher than population-based rare disease figures would suggest.

The reason the diagnosis is often delayed is not simply rarity; it is the combination of low clinical suspicion, overlapping pelvic symptoms, and frequently normal routine investigations. Many patients have already had normal urogynaecological, colorectal, or orthopaedic workups before the possibility of a pudendal neuropathic pain syndrome is even raised. That pattern strongly suggests underdiagnosis rather than true rarity.

The risk factors for pudendal neuralgia and pudendal entrapment are varied and may be acquired, anatomical, or functional. Acquired risk factors are more common and clinically more relevant.

Cycling deserves particular emphasis, especially in men, because it is one of the most recognisable triggers. Your source material notes that 50–91% of cyclists may report genital numbness, highlighting how common pudendal compression phenomena can be in that group, even if only a smaller subset progress to chronic neuralgia.

Anatomical variants are also worth remembering. The nerve may pass through unusual tissue planes or be more vulnerable because of variation in its relationship to the sacrotuberous ligament, sacrospinous ligament, or the distal canal. These variants help explain why some patients develop symptoms despite apparently modest provoking factors and why symptom patterns can vary between individuals.

Diagnostic Workup: Infographic-Style Clinical Pathway

The diagnostic workup for pudendal neuralgia should be systematic, but it should not become unnecessarily complicated. The central principle from your source material is that the diagnosis is primarily clinical, with imaging reserved for atypical presentations or red flags. When the classic criteria are met, there is no need to over-investigate.

Diagnostic pathway

Nantes criteria

The critical decision point is simple: if all five Nantes criteria are fulfilled and there are no red flags, treatment can proceed without further investigation. That principle is one of the most important messages in your source material and should be stated clearly in the article.

Imaging in Pudendal Neuralgia

Imaging in pudendal neuralgia is often misunderstood. It is not the routine basis of diagnosis. In a typical patient who meets the Nantes criteria and has no warning features, imaging is not required. That point is explicit in your uploaded material and should be stated strongly, because over-investigation can delay treatment and create confusion through incidental findings.

Imaging becomes important when there are red flags:

• nocturnal pain,
• objective sensory loss,
• focal pinpoint pain suggestive of neuroma,
• or additional neurological deficits.

In those circumstances, pelvic MRI is the investigation of choice because it can exclude malignancy, structural lesions, abscesses, haematomas, and other pelvic pathology that may mimic pudendal neuralgia. MRI is also helpful more broadly in differentiating other pelvic pain causes such as genitofemoral neuropathy, endometriosis, adenomyosis, or pelvic mass lesions.

Practical imaging decisions

One practical point worth emphasising is that incidental findings can be misleading. Tarlov cysts are a good example. Their presence on imaging does not prove causation. The article should caution readers not to mistake radiological abnormalities for the pain generator unless there is good clinical correlation.

MR Neurography and Nerve Conduction Studies

MR neurography and neurophysiological studies are attractive because they appear to offer objective confirmation, but  their role remains adjunctive, not foundational. The diagnosis remains primarily clinical.

MR neurography

High-resolution 3 Tesla MR neurography is the preferred advanced imaging technique when this route is taken. It allows visualisation of the pudendal nerve along its course and may show:

• increased T2 signal intensity at compression sites,
• nerve enlargement,
• calibre changes,
• or asymmetry compared with the opposite side.

However, the key limitation is accuracy. In one surgical series cited in your source documents, standard MR neurography agreed with operative findings in only 2 of 13 patients (15%). MR neurography should not be presented as a definitive diagnostic test for pudendal entrapment. It is often better at excluding alternative pathology than proving the diagnosis.

Interestingly, positive MR neurography findings may have more predictive value in men. In one study of 91 patients undergoing MR neurography and CT-guided blocks, positive MRN findings were associated with a better block response in men but not in women. That does not make MR neurography a routine test in men, but it does make it more defensible in selected uncertain male cases.

MR tractography

MR tractography, using diffusion tensor imaging, is a promising development. In the retrospective analysis cited in your files, tractography showed 85% correlation with surgical findings, compared with 15% for standard MR neurography. That is a striking difference. However, it remains investigational and is not yet something that can be presented as established routine practice.

Nerve conduction studies and ENMG

Standard electrophysiology has important limitations. Electroneuromyography and pudendal motor latency studies assess motor function, whereas many clinically relevant pudendal pain syndromes are primarily sensory. As a result, these tests have limited sensitivity and specificity. A normal study does not exclude pudendal neuralgia. They also cannot reliably distinguish entrapment from other causes of nerve injury such as prior surgery, childbirth trauma, or chronic constipation.

Their main usefulness is in selected preoperative assessment rather than routine diagnosis. When combined with imaging-guided infiltration, neurophysiological studies may help predict surgical outcome. Your source material cites combined sensitivity of 79%, specificity of 85.7%, and a positive predictive value of 98% for surgical success when neurophysiology and infiltration are used together.

Clinical integration

These tests can be useful in complex or preoperative cases, but they must not be allowed to displace the clinical diagnosis.

Conservative Management of Pudendal Neuralgia

Management should be stepwise and multimodal, starting with conservative measures and escalating only when necessary. Behavioural modification, pharmacotherapy, pelvic floor physiotherapy, and adjunctive treatments form the foundation of care.

Behavioural modification

The first step is reducing mechanical aggravation. Patients should be advised to avoid prolonged sitting where possible, change position regularly, and use cushions that offload the perineum. Cycling should be modified or stopped if it is a clear trigger. Activities that worsen symptoms—straining, squatting, or sustained pressure through the perineum—should be identified and reduced. These interventions may sound simple, but they are often clinically meaningful because they directly address the mechanical component of the syndrome.

Pharmacological management

Neuropathic pain medication is often appropriate, particularly when symptoms are established or widespread. Your uploaded material supports the use of:

• tricyclic antidepressants such as amitriptyline and nortriptyline,
• gabapentinoids such as gabapentin (1200–3600 mg/day) and pregabalin (150–600 mg/day),
• and SNRIs such as duloxetine (60–120 mg/day) or venlafaxine (150–225 mg/day).

Gabapentin plus nortriptyline may be more effective than either alone in some neuropathic pain settings when monotherapy is inadequate. Importantly, opioids are not recommended as a routine treatment for pudendal neuralgia, with expert consensus noting poor efficacy.

Pelvic floor physiotherapy

Pelvic floor physiotherapy is highly relevant, particularly in patients with hypertonicity, guarding, or myofascial pain. Internal and external myofascial release, trigger-point work, down-training, and relaxation strategies are more important here than strengthening. The goal is usually to reduce tone, restore controlled relaxation, and break the cycle in which pain produces spasm and spasm produces more pain.

TENS and adjuncts

In a randomised trial of 52 men with pudendal neuralgia, TENS plus physical therapy exercises resulted in significantly lower pain scores and reduced analgesic requirements compared with exercises alone after 12 weeks. That is clinically useful because it supports a more active conservative pathway rather than immediately escalating all patients to procedures.

Psychological support

Chronic pelvic neuropathic pain commonly affects mood, sleep, relationships, work, and self-confidence. Psychological support and pain-coping strategies are not substitutes for diagnosis, but they are important parts of care, especially in chronic or centrally sensitised cases. This should be part of a multimodal management rather than implying a psychogenic cause.

Pudendal Nerve Blocks

Pudendal nerve blocks are central to the diagnosis and management of pudendal neuralgia because they serve both diagnostic and therapeutic roles. A properly placed block can confirm the nerve as the pain generator while also giving meaningful—if sometimes temporary—symptom relief.

Blocks may be performed with CT guidance, fluoroscopy, ultrasound, or transvaginal landmark-based techniques, depending on expertise and anatomy. In contemporary specialist practice, image-guided approaches are preferable because they improve anatomical accuracy and reduce guesswork. The key anatomical targets are:

• the region of the ischial spine / interligamentous segment,
• and Alcock’s canal.

Injectates usually combine local anaesthetic with corticosteroid. The local anaesthetic provides immediate but short-lived confirmation and relief; the steroid may provide delayed benefit over subsequent weeks. Typical therapeutic effect from injection alone often declines over time:

• 49% of patients achieving ≥30% relief at 2 weeks in one series,
• 63% success at 1 month with dual-site CT-guided infiltration,
• 50% maintaining benefit at 3 months,
• and around 25% at 6 months.

That pattern is clinically important. It shows why nerve blocks are valuable, but also why they are often not a durable standalone solution in established disease.

A particularly useful concept is the dual-site approach. Because compression or irritation may occur both proximally between the ligaments and distally within Alcock’s canal, targeting both levels can improve outcomes in selected patients.  This supports blocking the pudendal nerve at both the sacrospinous–sacrotuberous ligament level and at Alcock’s canal.

Summary of block outcomes

Pulsed Radiofrequency for Pudendal Neuralgia

Pulsed radiofrequency (PRF) is an important intervention as it sits in the useful middle ground between repeated blocks and more invasive surgical treatment. PRF is non-ablative neuromodulation. Unlike destructive thermal radiofrequency, it delivers electromagnetic fields at controlled temperatures—typically around 42°C—with the aim of altering pain signalling without permanently destroying the nerve.

This makes PRF especially attractive in pudendal neuralgia, where one wants to modulate neuropathic pain while preserving function. It is most appropriate in patients who:

• have confirmed pudendal neuralgia,
• respond positively to diagnostic block,
• but obtain only short-lived benefit from injection alone,
• and either wish to avoid surgery or are not good surgical candidates.

In the Krijnen series, 79% of patients reported themselves as “very much better” or “much better” at 3 months, and 89% reported improvement at long-term follow-up with a median of 4 years. Other reported series in the file also show high response rates, although the evidence base is still dominated by case series and smaller trials rather than large definitive RCTs.

The main advantage of PRF over nerve blocks is duration. Whereas blocks often relieve symptoms for hours to weeks, sometimes a few months, PRF can provide relief lasting weeks to months, and in some cases much longer. It is also far less invasive than surgical decompression and can be repeated if the response is good but wanes over time.

PRF is promising, but the evidence remains limited compared with more established procedures in other pain fields. Duration of benefit varies, some patients require repeat treatments, and expert consensus still calls for longer follow-up and higher-quality evidence before blanket recommendations are made. That said, as a practical intermediate option after blocks and before surgery, it is very attractive.

PRF versus other options

Advanced and Surgical Options

Although you asked that the surgical section be kept shorter than the others, it still needs proper professional content. Surgery is generally reserved for confirmed entrapment in patients who have failed appropriate conservative and interventional care. A positive response to diagnostic pudendal block is an important predictor of surgical success and helps with patient selection.

Your source material summarises several decompression approaches, including laparoscopic transperitoneal, transperineal / pudendoscopy-based, transgluteal, and robot-assisted techniques. Meta-analytic data in the files suggest that laparoscopic approaches may report high success in selected hands, but overall outcomes vary, and technique choice depends heavily on surgical expertise and anatomical targets. Across all techniques, significant pain relief is reported in a meaningful proportion of patients, but outcomes are not uniform and earlier intervention may be associated with better improvement.

Neuromodulation—including sacral nerve stimulation, peripheral nerve stimulation, and dorsal root ganglion approaches—is also being explored for refractory disease. These options are relevant, but the long-term durability and ideal patient selection are still evolving. Emerging therapies such as cryotherapy, lipofilling, and rTMS remain investigational.

Pudendal Neuralgia in Men

Pudendal neuralgia in men deserves its own full section because it is often missed or mislabelled. Men may present with pain in the perineum, scrotum, penis, or rectum, usually worse with sitting and eased by standing, lying, or sometimes sitting on a toilet seat. The pain is often described as burning, sharp, electric, or as though sitting on a golf ball. Associated urinary, sexual, and bowel symptoms are common.

The distribution depends partly on which terminal branch is most affected:

• the dorsal nerve of the penis may produce penile pain, numbness, or dysaesthesia;
• the perineal nerve may produce scrotal or perineal discomfort;
• the inferior rectal nerve may produce proctalgia or rectal pain.

Male-specific causes include cycling, prolonged occupational sitting, pelvic trauma, radical prostatectomy, and pelvic radiation. Radiation-associated cases are especially important because they may be progressive and less clearly entrapment-based.

Differentiating Pudendal Neuralgia from Chronic Prostatitis / CPPS in Men

Pudendal neuralgia is frequently misdiagnosed as chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS), yet the two are not the same, even though they can overlap. Only about 33% of men labelled with CP/CPPS have histopathologic prostatic inflammation, and in one study cited in your material, men referred for chronic pelvic pain all had demonstrable pudendal neuropathy on quantitative sensory testing. At the same time, 27% had coexisting inflammatory prostatitis, which means the diagnoses are not mutually exclusive.

Key differences

The diagnostic pathway in men should therefore include:

• focused history,
• physical examination including pinprick sensory testing in pudendal territories,
• laboratory exclusion of infection,
• consideration of QST,
• and diagnostic pudendal block when clinically indicated.

Pinprick testing at six pudendal sites was abnormal in 92% of men with pudendal neuropathy in the cohort cited in your files. Warm detection threshold testing was abnormal in 100% in one cohort and may provide a “definite” diagnosis of pudendal neuropathy per IASP criteria, although it is not something used routinely in all centres.

When chronic pelvic pain in men is strongly provoked by sitting, neuropathic in quality, and not explained by infection or clear prostatic pathology, pudendal neuropathy must move high up the differential.

Pelvic Floor Hypertonicity and Pudendal Neuralgia

Pelvic floor hypertonicity is not a minor side issue; it is one of the most important perpetuating factors in chronic pudendal pain. Your source material presents this as a bidirectional relationship: pudendal nerve dysfunction can cause protective pelvic floor spasm, while chronic pelvic floor hypertonicity can itself contribute to pudendal nerve irritation or entrapment. That framework is clinically very helpful and should be kept.

The mechanisms can be summarised as follows:

The anatomical relationships are also important. The levator ani has dual innervation, and the pudendal nerve lies very close to related pelvic floor neural structures at the ischial spine. In practical terms, this means that pelvic floor symptoms and pudendal symptoms often coexist anatomically as well as clinically.

On examination, one should assess levator ani, obturator internus, and coccygeus tone and tenderness. Marked tenderness, involuntary guarding, and inability to relax on command support hypertonicity. This is one of the reasons why simply “blocking the nerve” is often insufficient in chronic cases; the muscular and myofascial driver also needs attention.

Role of Pelvic Floor Physiotherapy in Hypertonic Disorders

In hypertonic pelvic pain states, physiotherapy should focus on down-training and relaxation, not generic strengthening. Single-digit internal assessment and manual therapy may identify trigger points and areas of marked muscle guarding. Treatment can then include:

• manual myofascial release,
• trigger-point therapy,
• relaxation retraining,
• breathing and postural work,
• biofeedback where available,
• gradual restoration of normal pelvic floor coordination.

The role of physiotherapy is particularly important for patients whose symptoms flare with muscle tension, those with coexisting dyspareunia, pelvic floor tenderness, or patients who have partial but incomplete response to nerve procedures. In these patients, physiotherapy is not an optional extra; it is part of definitive treatment.

Intravaginal Diazepam and Other Muscle Relaxants

Intravaginal diazepam and other muscle relaxants are generally considered adjuncts, not primary treatments. Their rationale is straightforward: in selected patients with severe pelvic floor hypertonicity, reducing muscle tone may relieve a significant secondary driver of pudendal irritation.

However, the evidence base is much more limited than for mainstream neuropathic pain medication or procedural interventions. These treatments may have a place in carefully selected patients, particularly when physiotherapy identifies marked hypertonicity and internal muscle spasm.

They may be used selectively as part of a broader programme including pelvic floor physiotherapy, neuropathic medication where appropriate, and interventional care if needed.

A Practical Stepwise Treatment Algorithm

The overall treatment pathway should be clear and practical:

That algorithm fits the evidence and also fits real clinical practice. It avoids both undertreatment and premature escalation.

How We Treat Pudendal Neuralgia at Pain Spa

At Pain Spa, pudendal neuralgia should be presented not as a vague pelvic pain label, but as a condition requiring careful anatomical diagnosis, thoughtful patient selection, and precise image-guided treatment. That is where the practice’s strengths fit very naturally.

Dr Krishna has extensive experience in the assessment and treatment of complex pain syndromes, including neuropathic pelvic pain, and particular expertise in ultrasound-guided interventions. This matters because the pudendal nerve is small, deep, anatomically variable, and surrounded by clinically important structures. Accurate ultrasound-guided targeting improves precision and allows interventions to be tailored to the likely site and mechanism of pathology.

Treatments offered at Pain Spa

✅ Ultrasound-guided pudendal nerve block
Targeted block can be performed where the nerve lies between the sacrospinous and sacrotuberous ligaments, which is one of the classic sites of entrapment and irritation.

✅ Ultrasound-guided pudendal nerve block at Alcock’s canal
This distal approach is particularly relevant where symptoms suggest involvement of multiple terminal branches or where distal entrapment is suspected.

✅ Dual-site pudendal nerve blocks where appropriate
In selected patients, treating both the interligamentous segment and Alcock’s canal may improve diagnostic clarity and therapeutic effect, reflecting the anatomical reality that symptoms may arise from more than one potential compression point.

✅ Ultrasound-guided pulsed radiofrequency of the pudendal nerve
For patients who respond to block but obtain only short-lived relief, PRF provides a minimally invasive intermediate option that may offer longer-lasting improvement without destructive nerve injury.

✅ Ultrasound-guided pelvic floor muscle injections
Where pelvic floor hypertonicity and myofascial guarding are major contributors, targeted injections to pelvic floor muscles can be integrated into the treatment plan rather than focusing on the nerve alone.

The key message is that Pain Spa’s approach is comprehensive rather than one-dimensional. Assessment considers entrapment, neuropathy, pelvic floor dysfunction, and functional contributors together, and treatment is built around that full clinical picture.

Posterior Tibial Nerve Stimulation (PTNS): A Limited Rescue Option

Posterior tibial nerve stimulation (PTNS) has a limited but emerging role in pudendal neuralgia management. While it is primarily established for overactive bladder and has shown benefit in chronic pelvic pain more broadly, direct evidence for pudendal neuralgia specifically is sparse.

PTNS may be considered as a rescue option in carefully selected patients, particularly where there are concurrent urinary symptoms or when more direct implantable neuromodulation is not suitable. However, sacral nerve stimulation and direct pudendal nerve stimulation have more direct mechanisms and stronger relevance in refractory pudendal neuralgia.

The proposed mechanism is modulation of shared sacral root pathways, given that the posterior tibial nerve arises from L4–S3 and overlaps functionally with the S2–S4 roots contributing to the pudendal nerve. Existing chronic pelvic pain studies suggest short-term benefit in some patients, but long-term durability is limited and repeated maintenance sessions are often required.

In practical terms, PTNS should not be considered first-line treatment for pudendal neuralgia. It sits later in the pathway as a niche adjunct or rescue therapy, rather than a primary intervention.

Key Take-Home Messages

Pudendal neuralgia is best understood as a clinical neuropathic pelvic pain syndrome, not a diagnosis that can be ruled in or out by one scan or one test.

• • The Nantes framework remains central.
  • Imaging is selective, not routine.
  • Conservative measures and pelvic floor treatment matter.
  • Pudendal blocks are valuable diagnostically and therapeutically, but benefit may fade.
  • PRF is an important intermediate option for block responders.
  • In men, pudendal neuropathy is often hidden behind a label of chronic prostatitis or pelvic pain syndrome.
  • In complex cases, the most effective care comes from combining accurate anatomy, sound clinical reasoning, and precise image-guided treatment.